Head-to-head

Found vs Direct Meds

Compared on both medications across the eight dimensions this database records. They differ on 6 of those eight. Found is cheaper on all-in tirzepatide at 10 mg/week, though on a flat-versus-tiered matchup the cheaper program can change further up the dose ladder.

The short answer

Found is $289 a month all-in for tirzepatide; Direct Meds is $399. Over twelve months that is $3,468 against $4,788. Value Scores are 68.7 and 45.1 out of 100.

Tirzepatide

Plan pages: Found plans · Direct Meds plans

At 10 mg/week, Found is $289 a month all-in and Direct Meds is $399 — $110 apart, or $1,320 across a year. Over twelve months the totals are $3,468 (billed monthly) and $4,788 (billed monthly).

Found charges a flat $289 per month for tirzepatide at every dose from 2.5 to 15 mg per week, so titrating upward does not change what you pay.

Direct Meds prices tirzepatide by dose: $299 per month at 2.5 mg rising to $399 at 10 mg, a difference of $100 a month between the bottom and top of the ladder. The company publishes no price at 5, 7.5, 12.5, 15 mg, so those doses are left blank rather than estimated.

2.557.51012.515mg/week$289$289$289$289$289$289
Found in petrol against Direct Meds in graphite — all-in monthly tirzepatide cost at each dose. Second line: Direct Meds.
All-in monthly tirzepatide cost at each published dose, with each program's rank among everyone publishing at that dose
DoseFoundRankDirect MedsRankCheaper
2.5 mg$28915/31$29917/31Found by $10
5 mg$2898/17only Found publishes
7.5 mg$2898/17only Found publishes
10 mg$28910/27$39920/27Found by $110
12.5 mg$2898/17only Found publishes
15 mg$2898/17only Found publishes

Found is cheaper at every dose where both publish a price, so the lead does not change as you titrate.

Across the 27 programs this database can rank on tirzepatide, Found sits 9 of 27 on all-in monthly cost and Direct Meds sits 22. There are 12 other programs priced between them. The field median is $339 and the floor is $169, so Found is below the median and the other is above it. Found is $120 above the cheapest tirzepatide program on record. Direct Meds is $230 above the cheapest tirzepatide program on record.

LillyDirect (Zepbound), the lowest FDA-approved tirzepatide channel here, is $449 a month — Found undercuts it by $160, Direct Meds by $50. Compounded products are not FDA approved; insurance can reverse that comparison.

Published tirzepatide rates per month on each plan term
Plan termFoundDirect MedsCheaper
Month to month$289$399Found by $110
Twelve months of tirzepatide if you settled at each dose
Settled doseFoundDirect MedsDifference
2.5 mg$3,468$3,588$120 apart
5 mg$3,468one side unpriced
7.5 mg$3,468one side unpriced
10 mg$3,468$4,788$1,320 apart
12.5 mg$3,468one side unpriced
15 mg$3,468one side unpriced

Found publishes no rate for 3-month term, 6-month term, 12-month term; Direct Meds publishes none for 3-month term, 6-month term, 12-month term. An unpublished term is not necessarily unavailable — it is unpriced in public, which you can only resolve by asking.

A titration year is not twelve months at the maintenance price. Stepping up roughly four weeks per dose before settling at 10 mg/week, the first twelve months work out to $3,468 on Found and $4,688 on Direct Meds — $1,220 apart, and a different gap from the $1,320 you would get by multiplying the monthly difference by twelve. The ramp is cheaper than the settled rate on whichever program prices by dose, which is why a first-year quote and a steady-state quote are not the same number.

That calculation is partial: Direct Meds publishes no price at 2 of them, so the maintenance rate stands in for the missing steps rather than a number the company has stated.

Value Scores are 68.7 for Found and 45.1 for Direct Meds, against a tirzepatide category floor of $169. Found leads by 23.6 points, and the margin comes from structure rather than price alone.

Tirzepatide Value Score components
ProgramPrice /70Evidence /15Dose /10Membership /5Total /100
Found40.912.810568.7
Direct Meds29.610.50545.1

Semaglutide

Plan pages: Found plans · Direct Meds plans

At 2.4 mg/week, Found is $289 a month all-in and Direct Meds is $297 — $8 apart, or $96 across a year. Over twelve months the totals are $3,468 (billed monthly) and $3,564 (billed monthly).

Found charges a flat $289 per month for semaglutide at every dose from 0.25 to 2.4 mg per week, so titrating upward does not change what you pay.

Direct Meds prices semaglutide by dose: $249 per month at 0.25 mg rising to $297 at 2.4 mg, a difference of $48 a month between the bottom and top of the ladder. The company publishes no price at 0.5, 1, 1.7 mg, so those doses are left blank rather than estimated.

0.250.511.72.4mg/week$289$289$289$289$289
Found in petrol against Direct Meds in graphite — all-in monthly semaglutide cost at each dose. Second line: Direct Meds.

The lead changes with the dose. Between 0.25 mg and 2.4 mg it passes to Found. Pick on the dose you expect to settle at, not the headline.

Value Scores are 59.0 for Found and 45.9 for Direct Meds, against a semaglutide category floor of $129. Found leads by 13.1 points, and the margin comes from structure rather than price alone.

Where the two programs differ

All-in monthly

Found is cheaper month to month — $289 against $399, a gap of $110 every month, or $1,320 across a year if both rates hold.

Cancellation terms

Cancellation differs: Found states Per plan terms, while Direct Meds states Per provider terms. Read this next to the twelve-month figures — a prepaid discount and a restrictive refund policy are the same decision.

Commitment

Found asks for Program-based; Direct Meds asks for Monthly (no commitment indicated). This is the dimension most likely to change which program is actually cheaper for you, because the lowest rates on both sides are usually attached to the longest terms.

Dose policy

Found charges one price at every dose; Direct Meds prices by dose. That difference usually matters more than the headline gap, because the tiered program's advertised figure describes the dose you start on, not the dose you settle at.

Evidence status

The two prices are not equally well evidenced. Found's figure is provider-stated and Direct Meds's is reported. Found rests on the stronger of the two, and the Value Score below reflects that — evidence quality is worth fifteen points and is not a tiebreaker we apply after the fact.

Twelve-month cost

Over twelve months the totals are $3,468 for Found and $4,788 for Direct Meds. Found is lower by $1,320 — a figure worth checking against the cancellation terms below, because a prepaid year is only cheaper if you stay on it.

Membership fee

Neither charges a separate membership fee.

Shipping

Shipping is handled the same way by both — included in the quoted price.

What each record says

Found Official site

Found layers behavior-change coaching over medication access; compounded pricing lands at $289/month for tirzepatide and $289 at semaglutide maintenance (from a $169 start).

It does not publicly name its compounding pharmacy; the record shows Partner pharmacies, so who actually makes the medication cannot be independently verified; commitment terms are Program-based; cancellation is Per plan terms; availability is stated as Most US states.

Evidence: provider-stated — taken from the provider's own published pages; checkout capture pending, captured . Source — joinfound.com pricing capture 2026-08-05

Watch: Program bundles differ; confirm which plan a quoted price belongs to before comparing.

Direct Meds Official site

Direct Meds offers compounded GLP-1s in multiple formats — sublingual and injectable — with all-inclusive pricing verified on its own product pages. Semaglutide runs $249–$297/mo and tirzepatide $299–$399/mo depending on format; the lower figures are for sublingual delivery.

It does not publicly name its compounding pharmacy; the record shows Partner 503A pharmacy (not publicly named), so who actually makes the medication cannot be independently verified; commitment terms are Monthly (no commitment indicated); cancellation is Per provider terms; availability is stated as Confirm at intake.

Evidence: reported — sourced from dated third-party reporting; first-party capture pending, captured . Source — rangeyourself.com, Direct Meds product pages verified 2026-07-25

Watch: Pricing varies by format and page; product-page 'all-inclusive' rates differ from homepage promo cards. Rank is based on injectable rate as primary. Reported status — RangeYourself verified 2026-07-25 on Direct Meds' own product pages.

What neither record tells you

Found does not publish

  • no published twelve-month tirzepatide rate
  • no published twelve-month semaglutide rate
  • no named compounding pharmacy
  • no state-by-state availability list — it says Most US states
  • no specific cancellation or refund terms

Direct Meds does not publish

  • no tirzepatide price at 5, 7.5, 12.5, 15 mg per week
  • no published twelve-month tirzepatide rate
  • no semaglutide price at 0.5, 1, 1.7 mg per week
  • no published twelve-month semaglutide rate
  • no named compounding pharmacy
  • no state-by-state availability list — it says Confirm at intake
  • no specific cancellation or refund terms

Ask Found and Direct Meds for each of those in writing before enrolling. A gap is not evidence of a problem; it does mean nothing can be checked against it.

What would change this answer

Evidence may be upgraded. Direct Meds carries a price we have not captured at checkout. A capture would move the evidence term and could reorder these two without any price changing.

Which one suits which reader

On the lowest standing monthly rate for tirzepatide, Found Official site wins this matchup. If you expect to titrate to the top of the ladder, found's flat pricing is worth more than the headline gap suggests; and if you would rather trust a better-evidenced number, found's price rests on stronger provenance.

Both figures should be checked at the provider's own checkout before you pay. Found's tirzepatide price is provider-stated as of 2026-08-05; Direct Meds's is reported as of 2026-07-25.

Questions

Is Found or Direct Meds cheaper for tirzepatide?

Found is cheaper on all-in monthly cost at 10 mg/week: $289 against $399, a difference of $110 a month. All-in means the medication plus every mandatory recurring fee.

What is the twelve-month cost of Found versus Direct Meds?

Found works out to $3,468 across twelve months and Direct Meds to $4,788, on the plan terms each publishes.

Does Found or Direct Meds raise the price as the dose goes up?

Found: no, it charges one flat rate at every dose. Direct Meds: yes, it prices by dose. Where one program is flat and the other is tiered, the cheaper of the two can change as you titrate upward.

How many ways do Found and Direct Meds differ?

6 of the eight dimensions this site records: all-in monthly, twelve-month cost, dose policy, membership, shipping, commitment, cancellation terms and evidence status.

Which of Found and Direct Meds names its pharmacy?

Neither. Found records Partner pharmacies and Direct Meds records Partner 503A pharmacy (not publicly named). Without a named pharmacy, neither program's licensing or inspection history can be checked before you order.

How well evidenced are the Found and Direct Meds prices?

Found's tirzepatide figure is provider-stated — taken from the provider's own published pages; checkout capture pending — captured 2026-08-05. Direct Meds's is reported, captured 2026-07-25. Evidence status is worth fifteen points in the Value Score, so it is priced in rather than mentioned as an aside.

Which is cheaper for semaglutide?

Found, at $289 a month all-in against $297 at 2.4 mg/week. The two programs do not necessarily lead on both medications.

Official sources: Found official site · Direct Meds official site. Compounded tirzepatide and semaglutide are not FDA-approved products.